CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Repetitive Transcranial Magnetic Stimulation (rTMS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00529217
NCT00529217Phase 2Completed
CompareCT.gov

Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)

New York State Psychiatric Institute·interventional·Posted Sep 14, 2007·Updated Sep 22, 2014

In Brief

A Phase 2 clinical trial evaluating Repetitive Transcranial Magnetic Stimulation (rTMS) for Depersonalization Disorder. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the clinical efficacy of transcranial magnetic stimulation in the treatment of Depersonalization Disorder (DPD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepersonalization Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2007
Enrollment StartMay 1, 2006
Primary CompletionSep 1, 2010
Study CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 18.8 years ago

Interventions

Repetitive Transcranial Magnetic Stimulation (rTMS)device

Strong electromagnetic fields (\~2Tesla) generated briefly (\~1ms) but repetitively (1Hz) applied for 30mins, in five sessions per week for up to twelve weeks.